Echo Peptides compounds are third-party tested for identity and purity, with Certificates of Analysis published per batch as each lot is verified. Browse the certificates on file below — tap any document to enlarge.
These certificates reflect analytical verification used to support compound identification and quality review. Specific details vary by compound and batch. Each document is shown as the laboratory issued it and is dated by its own analysis date; where a report prints a personal e-mail address in its client field, that address is covered and nothing else is altered. For a certificate on a specific order or batch, contact support@echopeptides.co.
GHK-Cu · 100 mg11 June 2026Cagrilintide · 10 mg10 June 2026Retatrutide · 30 mg10 June 2026KLOW blend28 April 2026Retatrutide · 10 mg28 April 2026Retatrutide · 20 mg28 April 2026Semaglutide · 20 mg14 April 2026BPC-157 · 10 mg19 March 2026CJC-1295 + Ipamorelin19 March 2026Tesamorelin · 10 mg19 March 2026Tirzepatide · 20 mg19 March 2026MOTS-c · 10 mg12 February 2026BPC-157 · 5 mg10 December 2025Semaglutide · 10 mg10 December 2025Semax · 10 mg11 September 2025GLOW blend23 June 2025